{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:45:11Z","timestamp":1793159111949,"version":"4.5.0"},"reference-count":165,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T00:00:00Z","timestamp":1698883200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000870","name":"Pirbright Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000870","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Biology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jmb.2023.168297","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T03:28:34Z","timestamp":1696390114000},"page":"168297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["DNA Vaccines: History, Molecular Mechanisms and Future Perspectives"],"prefix":"10.1016","volume":"435","author":[{"given":"Sthefany","family":"Pagliari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1692-9987","authenticated-orcid":false,"given":"Barbara","family":"Dema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Sanchez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Montalvo Zurbia-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9712-8080","authenticated-orcid":false,"given":"Christine S.","family":"Rollier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmb.2023.168297_b0005","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/0042-6822(60)90182-3","article-title":"A tumor-producing factor extracted by phenol from papillomatous tissue (Shope) of cottontail rabbits","volume":"12","author":"Ito","year":"1960","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2023.168297_b0010","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/299740a0","article-title":"Cloned HBV DNA causes hepatitis in chimpanzees","volume":"299","author":"Will","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.jmb.2023.168297_b0015","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.1073\/pnas.83.24.9551","article-title":"Direct introduction of genes into rats and expression of the genes","volume":"83","author":"Benvenisty","year":"1986","journal-title":"Proc. Nat. Acad. Sci."},{"issue":"1990","key":"10.1016\/j.jmb.2023.168297_b0020","first-page":"1465","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168297_b0025","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/356152a0","article-title":"Genetic immunization is a simple method for eliciting an immune response","volume":"356","author":"Tang","year":"1992","journal-title":"Nature"},{"issue":"1993","key":"10.1016\/j.jmb.2023.168297_b0030","first-page":"1745","article-title":"Heterologous protection against influenza by injection of DNA encoding a viral protein","volume":"259","author":"Ulmer","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168297_b0035","doi-asserted-by":"crossref","first-page":"11478","DOI":"10.1073\/pnas.90.24.11478","article-title":"DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations","volume":"90","author":"Fynan","year":"1993","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.jmb.2023.168297_b0040","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1073\/pnas.90.9.4156","article-title":"Gene inoculation generates immune responses against human immunodeficiency virus type 1","volume":"90","author":"Wang","year":"1993","journal-title":"Proc. Nat. Acad. Sci."},{"key":"10.1016\/j.jmb.2023.168297_b0045","doi-asserted-by":"crossref","unstructured":"Thermet, A., Rollier, C., Zoulim, F., Trepo, C., Cova, L. (2003). Progress in DNA vaccine for prophylaxis and therapy of hepatitis B.","DOI":"10.1016\/S0264-410X(02)00575-3"},{"key":"10.1016\/j.jmb.2023.168297_b0050","unstructured":"Rollier, C., Sunyach, C., Barraud, L., Madani, N., Jamard, C., Trepo, C., Cova, L., (n.d.). Protective and Therapeutic Effect of DNA-Based Immunization Against Hepadnavirus Large Envelope Protein."},{"key":"10.1016\/j.jmb.2023.168297_b0055","doi-asserted-by":"crossref","unstructured":"Roy MacGregor, R., Boyer, J.D., Ugen, K.E., Lacy, K.E., Gluckman, S.J., Bagarazzi, M.L., Chattergoon, M.A., Baine, Y. et al. (n.d.). First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response https:\/\/academic.oup.com\/jid\/article\/178\/1\/92\/919924.","DOI":"10.1086\/515613"},{"issue":"1998","key":"10.1016\/j.jmb.2023.168297_b0060","first-page":"476","article-title":"Induction of Antigen-Specific Cytotoxic T Lymphocytes in Humans by a Malaria DNA Vaccine","volume":"282","author":"Wang","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.jmb.2023.168297_b0065","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13046-019-1154-7","article-title":"Cancer DNA vaccines: current preclinical and clinical developments and future perspectives","volume":"38","author":"Lopes","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jmb.2023.168297_b0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000053988","article-title":"Update on Antiviral DNA Vaccine Research (1998\u20132000)","volume":"43","author":"Schultz","year":"2000","journal-title":"Intervirology"},{"key":"10.1016\/j.jmb.2023.168297_b0075","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/cid\/cir334","article-title":"Clinical Applications of DNA Vaccines: Current Progress","volume":"53","author":"Ferraro","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jmb.2023.168297_b0080","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/pai.12964","article-title":"DNA and mRNA vaccination against allergies","volume":"29","author":"Scheiblhofer","year":"2018","journal-title":"Pediatr. Allergy Immunol."},{"key":"10.1016\/j.jmb.2023.168297_b0085","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1089\/hum.2018.066","article-title":"One Group\u2019s Historical Reflections on DNA Vaccine Development","volume":"29","author":"Fynan","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jmb.2023.168297_b0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1586\/14760584.2016.1124762","article-title":"Molecular mechanisms for enhanced DNA vaccine immunogenicity","volume":"15","author":"Li","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jmb.2023.168297_b0095","unstructured":"CDC and Fort Dodge Animal Health Achieve First Licensed DNA Vaccine, 2005. https:\/\/www.cdc.gov\/media\/pressrel\/r050718.htm."},{"key":"10.1016\/j.jmb.2023.168297_b0100","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.vaccine.2006.11.056","article-title":"Prospective immunization of the endangered California condors (Gymnogyps californianus) protects this species from lethal West Nile virus infection","volume":"25","author":"Chang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2023.168297_b0105","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1089\/vbz.2010.0173","article-title":"Efficacy of three vaccines in protecting Western Scrub-Jays (Aphelocoma californica) from experimental infection with West Nile virus: Implications for vaccination of Island Scrub-Jays (Aphelocoma insularis)","volume":"11","author":"Wheeler","year":"2011","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"10.1016\/j.jmb.2023.168297_b0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2174\/1872215611307010009","article-title":"Licensed DNA Vaccines against Infectious Hematopoietic Necrosis Virus (IHNV)","volume":"7","author":"Alonso","year":"2013","journal-title":"Recent Pat. DNA Gene Seq."},{"key":"10.1016\/j.jmb.2023.168297_b0115","unstructured":"Annual Report 2016, n.d."},{"key":"10.1016\/j.jmb.2023.168297_b0120","unstructured":"European Medicine Agency, First DNA vaccine in the EU recommended for use in salmon, (2016). https:\/\/www.ema.europa.eu\/en\/news\/first-dna-vaccine-eu-recommended-use-salmon."},{"key":"10.1016\/j.jmb.2023.168297_b0125","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/mt.2008.178","article-title":"Growth Hormone\u2013releasing Hormone Plasmid Treatment by Electroporation Decreases Offspring Mortality Over Three Pregnancies","volume":"16","author":"Person","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jmb.2023.168297_b0130","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/vco.12057","article-title":"A retrospective analysis of the efficacy of Oncept vaccine for the adjunct treatment of canine oral malignant melanoma","volume":"11","author":"Ottnod","year":"2013","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.jmb.2023.168297_b0135","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13567-019-0698-z","article-title":"Recent advances in delivery of veterinary DNA vaccines against avian pathogens","volume":"50","author":"Jazayeri","year":"2019","journal-title":"Vet. Res."},{"key":"10.1016\/j.jmb.2023.168297_b0140","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.3390\/pharmaceutics14091861","article-title":"Plasmid DNA for Therapeutic Applications in Cancer","volume":"14","author":"Mart\u00ednez-Puente","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jmb.2023.168297_b0145","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/imcb.12485","article-title":"Helicase antigen (HAGE)-derived vaccines induce immunity to HAGE and ImmunoBody\u00ae-HAGE DNA vaccine delays the growth and metastasis of HAGE-expressing tumors in vivo","volume":"99","author":"Nagarajan","year":"2021","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jmb.2023.168297_b0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.coi.2020.01.006","article-title":"DNA vaccines: prime time is now","volume":"65","author":"Gary","year":"2020","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jmb.2023.168297_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fmedt.2020.571030","article-title":"Harnessing Recent Advances in Synthetic DNA and Electroporation Technologies for Rapid Vaccine Development Against COVID-19 and Other Emerging Infectious Diseases","volume":"2","author":"Xu","year":"2020","journal-title":"Front Med Technol."},{"key":"10.1016\/j.jmb.2023.168297_b0160","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1056\/NEJMoa1708120","article-title":"Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine","volume":"385","author":"Tebas","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmb.2023.168297_b0165","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/infdis\/jiz132","article-title":"Intradermal SynCon\u00ae Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers","volume":"220","author":"Tebas","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jmb.2023.168297_b0170","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1473-3099(19)30266-X","article-title":"Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial","volume":"19","author":"Modjarrad","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jmb.2023.168297_b0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2217\/fvl-2021-0170","article-title":"A brief review on DNA vaccines in the era of COVID-19","volume":"17","author":"Shafaati","year":"2022","journal-title":"Future Virol."},{"key":"10.1016\/j.jmb.2023.168297_b0180","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/d41587-021-00023-5","article-title":"First COVID-19 DNA vaccine approved, others in hot pursuit","volume":"39","author":"Sheridan","year":"2021","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jmb.2023.168297_b0185","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(22)00151-9","article-title":"Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India","volume":"399","author":"Khobragade","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jmb.2023.168297_b0190","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4236\/wjv.2014.42008","article-title":"DNA Vaccines Approach: From Concepts to Applications","volume":"04","author":"Pereira","year":"2014","journal-title":"World J Vaccines."},{"key":"10.1016\/j.jmb.2023.168297_b0195","doi-asserted-by":"crossref","DOI":"10.1358\/dot.2018.54.5.2807864","article-title":"Plasmid DNA vaccines","volume":"54","author":"Ghaffarifar","year":"2018","journal-title":"Drugs Today."},{"key":"10.1016\/j.jmb.2023.168297_b0200","article-title":"DNA Vaccine: Mechanism of Action and Factors which Increase Its Efficacy","volume":"7","author":"Yurina","year":"2018","journal-title":"J. Reports Pharmaceut. Sci."},{"key":"10.1016\/j.jmb.2023.168297_b0205","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/path.1874","article-title":"Rational design of gene-based vaccines","volume":"208","author":"Barouch","year":"2006","journal-title":"J. Pathol."},{"key":"10.1016\/j.jmb.2023.168297_b0210","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.actbio.2018.08.033","article-title":"Engineering DNA vaccines against infectious diseases","volume":"80","author":"Lee","year":"2018","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jmb.2023.168297_b0215","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.PLAS-0028-2014","article-title":"Using Plasmids as DNA Vaccines for Infectious Diseases","volume":"2","author":"Tregoning","year":"2014","journal-title":"Microbiol Spectr."},{"key":"10.1016\/j.jmb.2023.168297_b0220","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/(SICI)1521-2254(200003\/04)2:2<76::AID-JGM97>3.0.CO;2-4","article-title":"Hypothesis: Naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process","volume":"2","author":"Budker","year":"2000","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jmb.2023.168297_b0225","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ni1028","article-title":"TLR9 signals after translocating from the ER to CpG DNA in the lysosome","volume":"5","author":"Latz","year":"2004","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jmb.2023.168297_b0230","doi-asserted-by":"crossref","unstructured":"Hayat Khan, K. (2013). DNA vaccines: roles against diseases. www.germs.ro.","DOI":"10.11599\/germs.2013.1034"},{"key":"10.1016\/j.jmb.2023.168297_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/S0264-410X(99)00171-1","article-title":"Manipulation of pathogen-derived genes to influence antigen presentation via DNA vaccines","volume":"17","author":"Rice","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2023.168297_b0240","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.0105-2896.2004.00141.x","article-title":"The processing of antigens delivered as DNA vaccines","volume":"199","author":"Howarth","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jmb.2023.168297_b0245","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: Ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jmb.2023.168297_b0250","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jbiotec.2012.08.012","article-title":"The future of human DNA vaccines","volume":"162","author":"Li","year":"2012","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.jmb.2023.168297_b0255","doi-asserted-by":"crossref","DOI":"10.2174\/156652311798192815","article-title":"Novel Strategies to Improve DNA Vaccine Immunogenicity","volume":"11","author":"Coban","year":"2011","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.jmb.2023.168297_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10408360490269251","article-title":"Approaches to Enhance the Efficacy of DNA Vaccines","volume":"41","author":"Manoj","year":"2004","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.jmb.2023.168297_b0265","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1016\/j.drudis.2021.06.008","article-title":"Methods to improve the immunogenicity of plasmid DNA vaccines","volume":"26","author":"Eus\u00e9bio","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jmb.2023.168297_b0270","series-title":"A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy","first-page":"213","article-title":"Adjuvant nanoformulations for tuberculosis vaccine delivery","author":"Harshavardhan","year":"2021"},{"key":"10.1016\/j.jmb.2023.168297_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7774\/cevr.2015.4.1.1","article-title":"Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases","volume":"4","author":"Grunwald","year":"2015","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.jmb.2023.168297_b0280","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4269\/ajtmh.17-0416","article-title":"Safety and immunogenicity of a tetravalent dengue DNA vaccine administered with a cationic lipid-based adjuvant in a phase 1 clinical trial","volume":"98","author":"Danko","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.jmb.2023.168297_b0285","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.0105-2896.2004.00200.x","article-title":"The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses","volume":"202","author":"Barouch","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jmb.2023.168297_b0290","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21775\/cimb.022.017","article-title":"Molecular Adjuvants for DNA Vaccines","volume":"22","author":"Li","year":"2017","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.jmb.2023.168297_b0295","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.vaccine.2006.07.034","article-title":"Novel codon-optimized GM-CSF gene as an adjuvant to enhance the immunity of a DNA vaccine against HIV-1 Gag","volume":"25","author":"Qiu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2023.168297_b0300","unstructured":"Kim, J.J., Yang, J.-S., Manson, K.H., Weiner, D.B. (2011). Modulation of antigen-specific cellular immune responses to DNA vaccination in rhesus macaques through the use of IL-2, IFN-g, or IL-4 gene adjuvants. http:\/\/www.elsevier.com\/locate\/vaccine."},{"key":"10.1016\/j.jmb.2023.168297_b0305","series-title":"Chemokine Gene Adjuvants Can Modulate Immune Responses Induced by DNA Vaccines","author":"Kim","year":"2000"},{"key":"10.1016\/j.jmb.2023.168297_b0310","doi-asserted-by":"crossref","DOI":"10.1086\/324371","article-title":"Immunization with an Interferon-g-gp120 Fusion Protein Induces Enhanced Immune Responses to Human Immunodeficiency Virus gp120","volume":"184","author":"Mccormick","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jmb.2023.168297_b0315","series-title":"Vaccine Adjuvants","article-title":"Adjuvant Activity of Cytokines","author":"Tovey","year":"2010"},{"key":"10.1016\/j.jmb.2023.168297_b0320","doi-asserted-by":"crossref","DOI":"10.1111\/j.0105-2896.2004.00150.x","article-title":"Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants","volume":"199","author":"Calarota","year":"2004","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jmb.2023.168297_b0325","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<1089::AID-IMMU1089>3.0.CO;2-L","article-title":"Modulation of amplitude and direction of in vivo immune responses by co-administration of cytokine gene expression cassettes with DNA immunogens","volume":"28","author":"Kim","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jmb.2023.168297_b0330","doi-asserted-by":"crossref","first-page":"5111","DOI":"10.1016\/j.vaccine.2008.03.089","article-title":"The effects of IL-6 and TNF-\u03b1 as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination","volume":"26","author":"Su","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2023.168297_b0335","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1016\/j.vaccine.2006.01.020","article-title":"Enhancement of immune responses to an HIV gp120 DNA vaccine by fusion to TNF alpha cDNA","volume":"24","author":"Nimal","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2023.168297_b0340","doi-asserted-by":"crossref","unstructured":"Scheerlinck, J.-P.Y. (2001). Genetic adjuvants for DNA vaccines. http:\/\/www.elsevier.com\/locate\/vaccine.","DOI":"10.1016\/S0264-410X(00)00495-3"},{"key":"10.1016\/j.jmb.2023.168297_b0345","article-title":"Suppressive effects on the immune response and protective immunity to a JEV DNA vaccine by co-administration of a GM-CSF-expressing plasmid in mice","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jmb.2023.168297_b0350","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.imlet.2014.08.005","article-title":"Variable effects of the co-administration of a GM-CSF-expressing plasmid on the immune response to flavivirus DNA vaccines in mice","volume":"162","author":"Chen","year":"2015","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jmb.2023.168297_b0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011021","article-title":"GM-CSF increases mucosal and systemic immunogenicity of an H1N1 influenza DNA vaccine administered into the epidermis of non-human primates","volume":"5","author":"Loudon","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jmb.2023.168297_b0360","doi-asserted-by":"crossref","DOI":"10.1111\/j.1348-0421.2005.tb03739.x","article-title":"Effect of Cytokine-Encoding Plasmid Delivery onImmune Response to Japanese Encephalitis Virus DNA Vaccine in Mice","volume":"49","author":"Bharati","year":"2005","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.jmb.2023.168297_b0365","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.imlet.2009.12.023","article-title":"Co-expression of Japanese encephalitis virus prM-E-NS1 antigen with granulocyte-macrophage colony-stimulating factor enhances humoral and anti-virus immunity after DNA vaccination","volume":"129","author":"Gao","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jmb.2023.168297_b0370","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.rvsc.2021.02.010","article-title":"Enhanced immunogenicity of foot and mouth disease DNA vaccine delivered by PLGA nanoparticles combined with cytokine adjuvants","volume":"136","author":"Yang","year":"2021","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.jmb.2023.168297_b0375","doi-asserted-by":"crossref","unstructured":"Ceissler, M., Cesien, A., Tokushige, K., Wands, J.R. (1997). Enhancement of Cellular and Humoral Immune Responses to Hepatitis C Virus Core Protein Using DNA-Based Vaccines Augmented with Cytokine-Expressing Plasmids\u2019, http:\/\/journals.aai.org\/jimmunol\/article-pdf\/158\/3\/1231\/1076114\/1231.pdf.","DOI":"10.4049\/jimmunol.158.3.1231"},{"key":"10.1016\/j.jmb.2023.168297_b0380","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1007\/s10529-009-0061-y","article-title":"Enhancing immune responses against SARS-cov nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in mice","volume":"31","author":"Hu","year":"2009","journal-title":"Biotechnol. Lett"},{"key":"10.1016\/j.jmb.2023.168297_b0385","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/JVI.76.1.243-250.2002","article-title":"Effects of Antigen and Genetic Adjuvants on Immune Responses to Human Immunodeficiency Virus DNA Vaccines in Mice","volume":"76","author":"Moore","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.jmb.2023.168297_b0390","doi-asserted-by":"crossref","unstructured":"Halwani, R., Boyer, J.D., Yassine-Diab, B., Haddad, E.K., Robinson, T.M., Kumar, S., Parkinson, R., Wu, L. (2008). Therapeutic Vaccination with Simian Immunodeficiency Virus (SIV)-DNAIL-12 or IL-15 Induces Distinct CD8 Memory Subsets in SIV-Infected Macaques 1, http:\/\/journals.aai.org\/jimmunol\/article-pdf\/180\/12\/7969\/1252559\/zim01208007969.pdf.","DOI":"10.4049\/jimmunol.180.12.7969"},{"key":"10.1016\/j.jmb.2023.168297_b0395","article-title":"IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine","volume":"17","author":"Xin","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2023.168297_b0400","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.4049\/jimmunol.164.6.3102","article-title":"The Timing of GM-CSF Expression Plasmid Administration Influences the Th1\/Th2 Response Induced by an HIV-1-Specific DNA Vaccine","volume":"164","author":"Kusakabe","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jmb.2023.168297_b0405","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000092487","article-title":"Co-expression of interleukin-2 by a bicistronic plasmid increases the efficacy of DNA immunization to prevent influenza virus infections","volume":"49","author":"Henke","year":"2006","journal-title":"Intervirology"},{"key":"10.1016\/j.jmb.2023.168297_b0410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029231","article-title":"Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and\/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults","volume":"7","author":"Kalams","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jmb.2023.168297_b0415","doi-asserted-by":"crossref","unstructured":"Egan, M.A., Israel, Z.R. (2002). The use of cytokines and chemokines as genetic adjuvants for plasmid DNA vaccines.","DOI":"10.1016\/S1529-1049(02)00051-X"},{"key":"10.1016\/j.jmb.2023.168297_b0420","doi-asserted-by":"crossref","unstructured":"Pertmer, T.M., Oran, A.E., Madorin, C.A., Robinson, H.L. (2001). Th1 genetic adjuvants modulate immune responses in neonates, http:\/\/www.elsevier.com\/locate\/vaccine.","DOI":"10.1016\/S0264-410X(00)00388-1"},{"key":"10.1016\/j.jmb.2023.168297_b0425","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2567.2009.03068.x","article-title":"Suppression of antitumour protective cytotoxic T lymphocyte responses to a human papillomavirus 16 E7 DNA vaccine by coinjection of interleukin-12 complementary DNA: Involvement of nitric oxide in immune suppression","volume":"128","author":"Sin","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.jmb.2023.168297_b0430","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1016\/j.vaccine.2008.02.036","article-title":"Combined effects of IL-12 and electroporation enhances the potency of DNA vaccination in macaques","volume":"26","author":"Hirao","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2023.168297_b0435","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1586\/erv.11.188","article-title":"Technologies for enhanced efficacy of DNA vaccines","volume":"11","author":"Saade","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jmb.2023.168297_b0440","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137079","article-title":"Robust antibody and cellular responses induced by DNA-only vaccination for HIV","volume":"5","author":"de Rosa","year":"2020","journal-title":"JCI Insight."},{"key":"10.1016\/j.jmb.2023.168297_b0445","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003019","article-title":"Phase 1 study of safety, tolerability and immunogenicity of the human telomerase (hTERT)-encoded DNA plasmids INO-1400 and INO-1401 with or without IL-12 DNA plasmid INO-9012 in adult patients with solid tumors","volume":"9","author":"Vonderheide","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jmb.2023.168297_b0450","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s00705-020-04669-5","article-title":"Immune effect of a Newcastle disease virus DNA vaccine with IL-12 as a molecular adjuvant delivered by electroporation","volume":"165","author":"Xie","year":"2020","journal-title":"Arch. Virol"},{"key":"10.1016\/j.jmb.2023.168297_b0455","first-page":"901","article-title":"Assessment of DNA vaccine encoding Toxoplasma gondii microneme complete gene and IL-12 as adjuvant in BALB\/c mice, Iran J Basic","volume":"22","author":"Ghaffarifar","year":"2019","journal-title":"Med. Sci."},{"key":"10.1016\/j.jmb.2023.168297_b0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104435","article-title":"Enhancing immune responses by a novel multi-epitope ROP8 DNA vaccine plus interleukin-12 plasmid as a genetic adjuvant against acute Toxoplasma gondii infection in BALB\/c mice","volume":"147","author":"Foroutan","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.jmb.2023.168297_b0465","first-page":"1","article-title":"Intramuscular and intradermal electroporation of hiv-1 pennvax-gp\u00ae DNA vaccine and IL-12 is safe, tolerable, acceptable in healthy adults","volume":"8","author":"Edupuganti","year":"2020","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.jmb.2023.168297_b0470","doi-asserted-by":"crossref","DOI":"10.3390\/v13091750","article-title":"Therapeutic potential of IL-15 and n-803 in HIV\/SIV infection","volume":"13","author":"Harwood","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jmb.2023.168297_b0475","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00109-002-0395-6","article-title":"Cytokine-facilitated priming of CD8+ T cell responses by DNA vaccination","volume":"81","author":"Kwissa","year":"2003","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.jmb.2023.168297_b0480","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.3748\/wjg.v12.i29.4727","article-title":"Coimmunization with IL-15 plasmid enhances the longevity of CD8 T cells induced by DNA encoding hepatitis B virus core antigen","volume":"12","author":"Zhang","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.jmb.2023.168297_b0485","doi-asserted-by":"crossref","DOI":"10.1016\/S0264-410X(99)00235-2","article-title":"HIV-1 DNA vaccines and chemokines","volume":"17","author":"Boyer","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2023.168297_b0490","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1016\/j.vaccine.2020.01.023","article-title":"CCR10 expression is required for the adjuvant activity of the mucosal chemokine CCL28 when delivered in the context of an HIV-1 Env DNA vaccine","volume":"38","author":"Gary","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2023.168297_b0495","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0042-6822(03)00417-3","article-title":"Enhanced immunogenicity of DNA fusion vaccine encoding secreted hepatitis B surface antigen and chemokine RANTES","volume":"314","author":"Kim","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2023.168297_b0500","article-title":"Mucosal chemokine adjuvant enhances synDNA vaccine-mediated responses to SARS-CoV-2 and provides heterologous protection in vivo","volume":"3","author":"Gary","year":"2022","journal-title":"Cell Rep Med."},{"key":"10.1016\/j.jmb.2023.168297_b0505","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/gt.2009.112","article-title":"Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo","volume":"17","author":"Kutzler","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.jmb.2023.168297_b0510","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/mi.2015.31","article-title":"Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge","volume":"9","author":"Kutzler","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jmb.2023.168297_b0515","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1016\/j.vaccine.2020.03.047","article-title":"Adenosine deaminase-1 enhances germinal center formation and functional antibody responses to HIV-1 Envelope DNA and protein vaccines","volume":"38","author":"Gary","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2023.168297_b0520","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.1016\/j.vaccine.2009.07.025","article-title":"Expression of tak1 and tram induces synergistic pro-inflammatory signalling and adjuvants DNA vaccines","volume":"27","author":"Larsen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2023.168297_b0525","unstructured":"Flo, J., Tisminetzky, S., Baralle, F. (n.d.). Modulation of the immune response to DNA vaccine by co-delivery of costimulatory molecules."},{"key":"10.1016\/j.jmb.2023.168297_b0530","unstructured":"Kim, J.J., Bagarazzi, M.L., Trivedi, N., Hu, Y., Kazahaya, K., Wilson, D.M., Ciccarelli, R., Chattergoon, M.A., Dang, K. et al. (1997). , Engineering of in vivo iITin1une responses to DNA iITIInunization via codelivery of costitnulatory Inolecule genes. http:\/\/www.nature.com\/naturebiotechnology."},{"key":"10.1016\/j.jmb.2023.168297_b0535","doi-asserted-by":"crossref","first-page":"50","DOI":"10.7774\/cevr.2012.1.1.50","article-title":"Mucosal vaccine adjuvants update","volume":"1","author":"Rhee","year":"2012","journal-title":"Clin Exp Vaccine Res."},{"key":"10.1016\/j.jmb.2023.168297_b0540","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1016\/j.vaccine.2008.03.091","article-title":"Improved HIV-1 specific T-cell responses by short-interval DNA tattooing as compared to intramuscular immunization in non-human primates","volume":"26","author":"Verstrepen","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2023.168297_b0545","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1586\/14760584.2015.990890","article-title":"Electroporation-enhanced delivery of nucleic acid vaccines","volume":"14","author":"Broderick","year":"2014","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jmb.2023.168297_b0550","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-04547-2","article-title":"Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques","volume":"7","author":"Todorova","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jmb.2023.168297_b0555","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00430-014-0384-8","article-title":"Electroporation for therapeutic DNA vaccination in patients","volume":"204","author":"S\u00e4llberg","year":"2015","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.jmb.2023.168297_b0560","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.4161\/hv.24702","article-title":"Tolerability of intramuscular and intradermal delivery by CELLECTRA\u00ae adaptive constant current electroporation device in healthy volunteers","volume":"9","author":"Diehl","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jmb.2023.168297_b0565","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/infdis\/jit236","article-title":"Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery","volume":"208","author":"Kalams","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jmb.2023.168297_b0570","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202753","article-title":"Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial","volume":"13","author":"Elizaga","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jmb.2023.168297_b0575","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.virol.2021.03.005","article-title":"Optimization of Zika DNA vaccine by delivery systems","volume":"559","author":"Lee","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.jmb.2023.168297_b0580","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/hgtb.2011.209","article-title":"Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device","volume":"23","author":"Lin","year":"2012","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.jmb.2023.168297_b0585","article-title":"A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19","author":"Aurisicchio","year":"2022","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jmb.2023.168297_b0590","doi-asserted-by":"crossref","unstructured":"Christou, P., Mccabe, D.E., Swain, W.F. (1988). Stable Transformation of Soybean Callus by DNA-Coated Gold Particles.","DOI":"10.1104\/pp.87.3.671"},{"key":"10.1016\/j.jmb.2023.168297_b0595","unstructured":"Nishizuka, Y.M., Berridge Irvine, R.F., Castagna, M., Chern\u00a0J.B., Kikkawa, Takai, U., Tanaka, Y., Miyake, Y., et al. (1984). High-velocity microprojectiles for delivering nucleic acids into living cells"},{"key":"10.1016\/j.jmb.2023.168297_b0600","doi-asserted-by":"crossref","unstructured":"Sanford, J.C., Smith, F.D., Russell, J.A. (1993). Optimizing the Biolistic Process for Different Biological Applications.","DOI":"10.1016\/0076-6879(93)17086-K"},{"key":"10.1016\/j.jmb.2023.168297_b0605","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/abio.1994.1108","article-title":"Gene transfer into mammalian cells by particle bombardment","volume":"217","author":"Heiser","year":"1993","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jmb.2023.168297_b0610","doi-asserted-by":"crossref","unstructured":"Larregina, A.T., Watkins, S.C., Erdos, G., Spencer, L.A., Storkus, W.J., Stolz, D.B., Falo, L.D. (2001). Direct transfection and activation of human cutaneous dendritic cells, http:\/\/www.nature.com\/gt.","DOI":"10.1038\/sj.gt.3301404"},{"key":"10.1016\/j.jmb.2023.168297_b0615","doi-asserted-by":"crossref","unstructured":"Choi, A.H.-C., Knowlton, D.R., McNeal, M.M., Ward, R.L. (1997). Particle Bombardment-Mediated DNA Vaccination with Rotavirus VP6 Induces High Levels of Serum Rotavirus IgG but Fails to Protect Mice against Challenge.","DOI":"10.1006\/viro.1997.8552"},{"key":"10.1016\/j.jmb.2023.168297_b0620","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.clim.2016.08.021","article-title":"Immunization with electroporation enhances the protective effect of a DNA vaccine candidate expressing prME antigen against dengue virus serotype 2 infection","volume":"171","author":"Chen","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jmb.2023.168297_b0625","article-title":"Engineering Biomaterials to Direct Innate Immunity","volume":"2","author":"Oakes","year":"2019","journal-title":"Adv Ther (Weinh)."},{"key":"10.1016\/j.jmb.2023.168297_b0630","unstructured":"Caudill, C., Perry, J.L., Iliadis, K., Tessema, A.T., Lee, B.J., Mecham, B.S., Tian, S., DeSimone, J.M. (n.d.). Transdermal vaccination via 3D-printed microneedles induces potent humoral and cellular immunity. https:\/\/doi.org\/10.1073\/pnas.2102595118\/-\/DCSupplemental."},{"key":"10.1016\/j.jmb.2023.168297_b0635","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/10717541003667798","article-title":"Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety","volume":"17","author":"Donnelly","year":"2010","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jmb.2023.168297_b0640","first-page":"945","article-title":"Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine","volume":"7","author":"Hong","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.jmb.2023.168297_b0645","doi-asserted-by":"crossref","unstructured":"O\u2019shea, J., Prausnitz, M.R., Rouphael, N. (2021). Dissolvable Microneedle Patches to Enable Increased Access to Vaccines against SARS-CoV-2 and Future Pandemic Outbreaks. https:\/\/doi.org\/10.3390\/vaccines.","DOI":"10.3390\/vaccines9040320"},{"key":"10.1016\/j.jmb.2023.168297_b0650","first-page":"195","article-title":"Long-term stability of influenza vaccine in a dissolving microneedle patch, Drug Deliv","volume":"7","author":"Mistilis","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.jmb.2023.168297_b0655","doi-asserted-by":"crossref","DOI":"10.1021\/acsnano.1c03252","article-title":"Separable Microneedle Patch to Protect and Deliver DNA Nanovaccines against COVID-19","author":"Yin","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jmb.2023.168297_b0660","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/CCID.S162724","article-title":"Current trends in needle-free jet injection: An update","volume":"11","author":"Barolet","year":"2018","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"10.1016\/j.jmb.2023.168297_b0665","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059340","article-title":"DNA Vaccine Delivered by a Needle-Free Injection Device Improves Potency of Priming for Antibody and CD8+ T-Cell Responses after rAd5 Boost in a Randomized Clinical Trial","volume":"8","author":"Graham","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jmb.2023.168297_b0670","unstructured":"ZyCoV-D SmPc & Factsheet, (n.d.)."},{"key":"10.1016\/j.jmb.2023.168297_b0675","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1016\/j.vaccine.2009.04.033","article-title":"Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime\/protein boost vaccination regimen in mice","volume":"27","author":"Bivas-Benita","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2023.168297_b0680","doi-asserted-by":"crossref","unstructured":"Rajapaksa, A.E., Ho, J.J., Qi, A., Bischof, R., Nguyen, T.-H., Tate, M., Piedrafita, D., Mcintosh, M.P., (2014). Effective pulmonary delivery of an aerosolized plasmid DNA vaccine via surface acoustic wave nebulization. http:\/\/respiratory-research.com\/content\/15\/1\/60http:\/\/respiratory-research.com\/content\/15\/1\/60.","DOI":"10.1186\/1465-9921-15-60"},{"key":"10.1016\/j.jmb.2023.168297_b0685","doi-asserted-by":"crossref","unstructured":"Lallow, E.O., Jhumur, N.C., Ahmed, I., Kudchodkar, S.B., Roberts, C.C., Jeong, M., Melnik, J.M., Park, S.H., et al. (2021). B I O E N G I N E E R I N G Novel suction-based in vivo cutaneous DNA transfection platform.","DOI":"10.1126\/sciadv.abj0611"},{"key":"10.1016\/j.jmb.2023.168297_b0690","doi-asserted-by":"crossref","DOI":"10.3389\/fviro.2022.891540","article-title":"Immune Responses of a Novel Bi-Cistronic SARS-CoV-2 DNA Vaccine Following Intradermal Immunization With Suction Delivery","volume":"2","author":"Jeong","year":"2022","journal-title":"Frontiers in Virology."},{"key":"10.1016\/j.jmb.2023.168297_b0695","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ijid.2022.12.037","article-title":"Safety and immunogenicity of the bi-cistronic GLS-5310 COVID-19 DNA vaccine delivered with the GeneDerm suction device","volume":"128","author":"Kim","year":"2023","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.jmb.2023.168297_b0700","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.3390\/vaccines11061016","article-title":"DNA Vaccines for Epidemic Preparedness: SARS-CoV-2 and Beyond","volume":"11","author":"Maslow","year":"2023","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.jmb.2023.168297_b0705","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1089\/hum.2017.197","article-title":"Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases","volume":"29","author":"Cheng","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jmb.2023.168297_b0710","first-page":"109","article-title":"Recent advances towards the clinical application of DNA vaccines","volume":"71","author":"Bins","year":"2013","journal-title":"Neth J Med."},{"key":"10.1016\/j.jmb.2023.168297_b0715","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3390\/vaccines7020037","article-title":"Comparison of Plasmid DNA and mRNA as Vaccine Technologies","volume":"7","author":"Liu","year":"2019","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.jmb.2023.168297_b0720","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4161\/hv.2.2.2620","article-title":"Preclinical and Clinical Safety Studies on DNA Vaccines","volume":"2","author":"Schalk","year":"2006","journal-title":"Hum. Vaccin."},{"key":"10.1016\/j.jmb.2023.168297_b0725","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/sj.gt.3302213","article-title":"Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation","volume":"11","author":"Wang","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.jmb.2023.168297_b0730","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000053993","article-title":"Plasmid DNA Vaccines: Investigation of Integration into Host Cellular DNA following Intramuscular Injection in Mice","volume":"43","author":"Ledwith","year":"2000","journal-title":"Intervirology"},{"key":"10.1016\/j.jmb.2023.168297_b0735","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1016\/j.vaccine.2009.11.025","article-title":"FDA guidance on prophylactic DNA vaccines: Analysis and recommendations","volume":"28","author":"Klinman","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jmb.2023.168297_b0740","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/hum.1997.8.3-293","article-title":"Do DNA Vaccines Induce Autoimmune Disease?","volume":"8","author":"Mor","year":"1997","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jmb.2023.168297_b0745","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1586\/14760584.8.2.239","article-title":"Recent advances in DNA vaccines for autoimmune diseases","volume":"8","author":"Silva","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jmb.2023.168297_b0750","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1586\/erv.10.57","article-title":"DNA vaccines for targeting bacterial infections","volume":"9","author":"Ingolotti","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jmb.2023.168297_b0755","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.3390\/ijms19113605","article-title":"DNA Vaccines\u2014How Far From Clinical Use?","volume":"19","author":"Hobernik","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmb.2023.168297_b0760","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.861710","article-title":"STING Is Required in Conventional Dendritic Cells for DNA Vaccine Induction of Type I T Helper Cell- Dependent Antibody Responses","volume":"13","author":"Ulrich-Lewis","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jmb.2023.168297_b0765","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1365-2567.2004.01938.x","article-title":"TLR9-\/- and TLR9+\/+ mice display similar immune responses to a DNA vaccine","volume":"113","author":"Babiuk","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.jmb.2023.168297_b0770","doi-asserted-by":"crossref","unstructured":"Hayat Khan, K. (2013). DNA vaccines: roles against diseases. http:\/\/www.germs.ro.","DOI":"10.11599\/germs.2013.1034"},{"key":"10.1016\/j.jmb.2023.168297_b0775","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3390\/v13020258","article-title":"The key role of nucleic acid vaccines for one health","volume":"13","author":"Fomsgaard","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jmb.2023.168297_b0780","doi-asserted-by":"crossref","unstructured":"Rollier, C., Verschoor, E.J., Paranhos-Baccala, G., Drexhage, J.A.R., Verstrepen, B.E., Berland, J.-L., Himoudi, N., Barnfield, C., et al. (n.d.) Modulation of Vaccine-Induced Immune Responses to Hepatitis C Virus in Rhesus Macaques by Altering Priming before Adenovirus Boosting, https:\/\/academic.oup.com\/jid\/article\/192\/5\/920\/804103.","DOI":"10.1086\/432517"},{"key":"10.1016\/j.jmb.2023.168297_b0785","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/gt.2016.55","article-title":"T-and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates","volume":"23","author":"Rollier","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.jmb.2023.168297_b0790","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jgm.669","article-title":"DNA vaccination against tumors","volume":"7","author":"Prud\u2019homme","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jmb.2023.168297_b0795","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2051-1426-1-20","article-title":"Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma","volume":"1","author":"Yuan","year":"2013","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jmb.2023.168297_b0800","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1086\/420792","article-title":"Protection against Challenge with Measles Virus (MV) in Infant Macaques by an MV DNA Vaccine Administered in the Presence of Neutralizing Antibody","volume":"189","author":"Premenko-Lanier","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jmb.2023.168297_b0805","first-page":"174","article-title":"A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge, Cancer","volume":"7","author":"Duperret","year":"2019","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jmb.2023.168297_b0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118919","article-title":"DNA vaccines against COVID-19: Perspectives and challenges","volume":"267","author":"Silveira","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.jmb.2023.168297_b0815","doi-asserted-by":"crossref","unstructured":"Liu, M.A., Citation: Liu, M.A. (2022). DNA and mRNA Vaccines for Chronic Viral Infections DNA and mRNA Vaccines for Chronic Viral Infections and Cancer: Rationale, Mechanisms, and Progress. https:\/\/doi.org\/10.3390\/cancers.","DOI":"10.3390\/cancers14235874"},{"key":"10.1016\/j.jmb.2023.168297_b0820","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12185-016-2110-3","article-title":"Safety of ASP0113, a cytomegalovirus DNA vaccine, in recipients undergoing allogeneic hematopoietic cell transplantation: an open-label phase 2 trial","volume":"105","author":"Mori","year":"2017","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.jmb.2023.168297_b0825","doi-asserted-by":"crossref","unstructured":"De Rosa, S.C., Thomas, E.P., Bui, J., Huang, Y., Decamp, A., Morgan, C., Kalams, S., Tomaras, G.D., et al. (n.d.). HIV-DNA priming alters T-cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable1, https:\/\/doi.org\/10.4049\/jimmunol.1101421.","DOI":"10.4049\/jimmunol.1101421"}],"container-title":["Journal of Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283623004084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022283623004084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:26:56Z","timestamp":1762669616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022283623004084"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":165,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0022283623004084"],"URL":"https:\/\/doi.org\/10.1016\/j.jmb.2023.168297","relation":{},"ISSN":["0022-2836"],"issn-type":[{"value":"0022-2836","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA Vaccines: History, Molecular Mechanisms and Future Perspectives","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmb.2023.168297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"168297"}}